Remdesivir- Ivermectin Combination Therapy in Severe Covid-19
Status:
Not yet recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
Recent study reported in vitro synergistic interaction between two FDA approved drugs,
remdesivir (RDV) and ivermectin (IVM) resulting in enhanced antiviral activity against
SARS-CoV-2, the causative pathogen of COVID-19. The aim of the current study is comparing the
efficacy and safety of combining remdesivir and ivermectin versus using remdesivir alone in
patients with severe COVID-19.